
The purpose of this study was to evaluate the diagnostic efficacy and safety of an intravenous injection of magnetic resonance imaging zzso contrast agent, zzso U 555 A, in adult patients with known focal liver zzso zzso and zzso image sets were obtained in 19 patients after injection of zzso U 555 A as a part of a phase III clinical trial zzso zzso zzso body weight received zzso zzso and patients zzso zzso received zzso zzso Three blinded readers evaluated the zzso zzso Blood pressure and heart rate were recorded and laboratory tests were performed at zzso during and immediately after the zzso and four and 24 hours after the MR zzso On zzso zzso there was statistically significant improvement in diagnostic confidence, zzso zzso and contrast between the zzso and the healthy zzso in comparison to zzso Twenty more zzso were detected on zzso zzso The management in six patients zzso was changed after zzso zzso Changes in vital signs and laboratory tests were minimal and did not affect the patients' clinical zzso Only a moderate allergic reaction zzso zzso zzso was zzso zzso U 555 A is an effective and safe contrast agent for zzso of the zzso 

